What: Chief Healthcare Executive examines the growing business case for increased funding in women’s health, forecasting new opportunities and challenges.
Key line: [Details not provided].
Source: Chief Healthcare Executive.
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
Oprah opens up about her menopause journey and brings national attention to a long-ignored health topic.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
Critical care doctors reveal fatal consequences of abortion bans in new interviews.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
A study finds women with incontinence are more likely to have heart disease risk factors.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Women who start menopause before age 40 may face faster cognitive decline.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
A blood test may soon predict postpartum depression before symptoms arise.
A small increase in births among women in their 30s and 40s offsets younger declines.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
The influential Women’s Health Initiative will shut down without federal support.